News|Articles|November 17, 2026

Urban Hospital Care Linked to Better HFrEF Outcomes for Rural Patients

Fact checked by: Ashley Gallagher, MA
Listen
0:00 / 0:00

Key Takeaways

  • Rural patients hospitalized at urban centers had markedly higher inpatient cardiology consultation and greater use of key GDMT classes, yet achievement of ≥50% target doses improved inconsistently.
  • Treatment at urban hospitals correlated with lower 90-day mortality and reduced 1-year HF readmission versus rural-hospital care, but timely 14-day outpatient follow-up was less frequent.
SHOW MORE

Rural patients with HFrEF had lower mortality when treated at urban hospitals but higher early mortality than urban patients at those hospitals.

Rural patients hospitalized for heart failure with reduced ejection fraction (HFrEF) at urban hospitals received more cardiology consultations and guideline-directed medical therapy (GDMT) and had lower mortality than rural patients treated at rural hospitals, yet they still faced higher short-term mortality than urban patients treated at the same urban hospitals, according to a study published in JAMA Cardiology.1

Although rural-urban disparities in heart failure (HF) are well documented, it has been unclear whether they stem mainly from where patients live, the hospitals that treat them, or both. To find out, the researchers studied 735,460 Medicare fee-for-service beneficiaries (median age, 77 years) discharged alive after an index HFrEF hospitalization between 2013 and 2021, sorting them into 4 groups: rural patients in rural hospitals (9.4%), rural patients in urban hospitals (8.9%), urban patients in urban hospitals (79.3%), and urban patients in rural hospitals (2.4%). The primary outcome was 90-day all-cause mortality after hospitalization.

Urban Hospital Care Tied to More GDMT and Lower Mortality for Rural Patients

Compared with rural patients treated at rural hospitals, rural patients treated at urban hospitals had about twice the odds of receiving an inpatient cardiology consultation (OR, 2.02; 95% CI, 1.84-2.22). At 90 days after discharge, they had higher use of β-blockers (OR, 1.20; 95% CI, 1.16-1.25), angiotensin receptor-neprilysin inhibitors (OR, 1.23; 95% CI, 1.13-1.34), mineralocorticoid receptor antagonists (OR, 1.23; 95% CI, 1.15-1.31), and sodium-glucose cotransporter 2 inhibitors (OR, 1.48; 95% CI, 1.32-1.67). However, gains in reaching at least 50% of target doses were inconsistent and modest.

Rural patients treated at urban hospitals also had lower rates of HF readmission and death at all time points, including 90-day mortality (OR, 0.94; 95% CI, 0.91-0.97), 1-year HF readmission (OR, 0.85; 95% CI, 0.82-0.88), and 1-year mortality (OR, 0.91; 95% CI, 0.89-0.94). Still, they were less likely to complete outpatient follow-up within 14 days (OR, 0.90; 95% CI, 0.84-0.96), which the authors said may reflect difficulty accessing local care after discharge from a hospital farther from home.

The authors noted that these differences likely reflect broader regional gaps in access to cardiovascular care rather than hospital resources alone. A 2024 analysis published in the Journal of the American College of Cardiology found that 46.3% of US counties, home to 22 million residents, had no practicing cardiologist, including 86.2% of rural counties.2

Rural Residence Linked to Higher Early Mortality, Even at Urban Hospitals

When the researchers compared rural and urban patients treated at urban hospitals, rural patients more often received inpatient cardiology consultation (OR, 1.38; 95% CI, 1.31-1.44), while differences in postdischarge GDMT were modest (absolute difference in GDMT score, 0.09 points; 95% CI, 0.05-0.14). Rural patients also had lower HF readmission at 1 year (OR, 0.81; 95% CI, 0.79-0.82).

Even so, rural patients had higher mortality at 30 days (OR, 1.10; 95% CI, 1.06-1.14) and 90 days (OR, 1.05; 95% CI, 1.02-1.08), with no significant difference at 1 year. The authors said this suggests the early risk of decompensation after HF hospitalization may be particularly pronounced for rural patients, with social determinants of health, delayed follow-up, and medication affordability as possible contributors. They added that lower readmission rates among rural patients may reflect barriers to access rather than better clinical stability.

Limitations included the observational design and possible residual confounding; rural patients who sought care at urban hospitals may have had greater resources or social support than those treated locally. The authors pointed to transitional care, telehealth-based follow-up, outpatient medication optimization programs, and better coordination between urban centers and rural clinics as ways to reduce early postdischarge mortality gaps.

“Results suggest that hospital rurality was associated with lower odds of GDMT use and higher rates of all-cause mortality, whereas rural residence was associated with mortality differences despite treatment in urban hospitals,” wrote the researchers of the study. “Interventions addressing both inpatient resource disparities and postdischarge transitions of care may reduce rural-urban inequities in HF outcomes.”

References

  1. Verma A, Fan J, Wei C, et al. Intersection of Patient and hospital rurality in heart failure care and outcomes. JAMA Cardiol. Published online October 30, 2026. doi:10.1001/jamacardio.2026.4827
  2. No practicing cardiologist in nearly half of US counties, despite higher CV and mortality risk. American College of Cardiology. July 8, 2024. Accessed November 17, 2026. https://www.acc.org/Latest-in-Cardiology/Articles/2024/07/08/11/54/No-Practicing-Cardiologist-in-Nearly-Half-of-US-Counties

Related to this article